CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We submit herewith the confirmation certificate received from M/s Purva Sharegistry (India) Private Limited, Registrar and Share Transfer Agent (RTA) as per regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2020. CHEMO PHARMA LABORATORIES LTD. - 506365 - Please Find Enclosed The Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2020.
Please find enclosed the certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended March 31, 2020. CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholding for the Period Ended March 31, 2020
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here CHEMO PHARMA LABORATORIES LTD. - 506365 - Pursuant To Regulation 40(10) Of The Listing Regulations, Please Find Enclosed Herewith A Certificate Issued By M/S. S. K. Jain & Co., Practicing Company Secretary, Mumbai For The Half Year Ended 31St March, 2020. This Is For Your Information And Record.
Pursuant to Regulation 40(10) of the Listing Regulations, please find enclosed herewith a certificate issued by M/s. S. K. Jain & Co., Practicing Company Secretary, Mumbai for the half year ended 31st March, 2020. This is for your information and record. CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Managing Director / Whole Time Director CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
We would like to inform you that as per the Company''s Code of Conduct formulated pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for trading in the securities of the Company will be closed for all Directors and Employees of the Company from 01st April, 2020 and would remain closed till 48 hours after the announcement of Audited financial results for the quarter ending on 31st March, 2020 to the public (both days inclusive). Accordingly, all directors and employees of the Company have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. The above is for your information and record. Chemo Pharma Laboratories Ltd - 506365 - Submission Of Un-Audited Financial Results For The Quarter Ended 31.12.2019
Submission of Un-Audited Financial Results for the quarter ended 31.12.2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Outcome Of Board Meeting For The Quarter Ended 31.12.2019
Outcome of Board Meeting for the quarter ended 31.12.2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholding for the Period Ended December 31, 2019
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2019